ICD-10-CM Billable Code

M89.071

Algoneurodystrophy, right ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Algoneurodystrophy, also known as Complex Regional Pain Syndrome (CRPS), is a chronic pain condition that typically affects a limb after injury or trauma. When it involves the right ankle and foot, it can lead to persistent discomfort, swelling, and changes in skin and bone. This condition is characterized by abnormal nerve function and an ongoing inflammatory response that amplifies pain and sensory disturbances, often disproportionate to the initial injury.

Causes & Symptoms

Clinical Causes: Injury or trauma to the ankle and foot, such as fractures, sprains, or surgery Nerve damage or abnormal nerve signaling following injury Reduced mobility or immobilization after injury Certain medical conditions like infections or autoimmune disorders may trigger CRPS Genetic predispositions that affect nerve sensitivity and inflammatory responses

Key Symptoms: Severe, burning or stabbing pain in the affected limb Swelling and changes in skin color and temperature Sensitivity to touch or even light contact (allodynia) Stiffness and decreased range of motion in the ankle and foot Changes in skin texture, either becoming shiny or moist Bone thinning or abnormal bone growth visible on imaging Muscle weakness or atrophy over time Abnormal sweating or hair and nail growth in the affected area

Diagnostic & Treatment

Diagnosis Path: Diagnosis of algoneurodystrophy involves a comprehensive clinical evaluation, including a detailed history of injury or trauma, physical examination, and imaging studies. Physicians may use diagnostic criteria such as the Budapest Criteria, which assess sensory, vasomotor, sudomotor, and motor/trophic changes. Imaging techniques like MRI, bone scans, or thermography help identify characteristic changes in blood flow, bone density, and tissue appearance. There are no specific laboratory tests for CRPS, making clinical judgment essential.

Treatment Protocols: Managing algoneurodystrophy typically involves a multidisciplinary approach aimed at reducing pain, restoring function, and preventing progression. Common treatments include: - **Medications:** Pain relievers, nerve blocks, anti-inflammatory drugs, and medications targeting nerve pain such as gabapentin or pregabalin. - **Physical Therapy:** Guided exercises to improve range of motion, strength, and reduce stiffness. - **Psychological Interventions:** Techniques like cognitive-behavioral therapy to address pain perception and emotional well-being. - **Sympathetic Nerve Blocks:** Injections that can help alleviate pain by disrupting nerve signaling. - **Alternative Therapies:** Acupuncture and biofeedback may provide additional relief. - **Lifestyle Modifications:** Elevation, skin care, and avoiding further injury are crucial parts of management. Prompt and continuous treatment can improve outcomes and decrease the likelihood of long-term disability.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M89.071 a billable ICD-10 code?
Yes, M89.071 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M89.071?
Clinical documentation must specify the nature of Algoneurodystrophy, right ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference